Infectious Diseases News and Research

RSS

Deep learning identifies novel compounds against antibiotic-resistant gonorrhea

With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). Alone in the U.S., over 600,000 cases are reported each year.

17 Jun 2026

WashU study identifies shared target for a new diarrhea vaccine

The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children.

17 Jun 2026

Houston Methodist study reveals how strep bacterium causes infection

A fast-rising strep bacterium has become increasingly notorious for causing serious infections in humans, including complications that can lead to muscle damage and patient death. New Houston Methodist research appearing in The American Journal of Pathology, published by Elsevier, sheds light on how Streptococcus dysgalactiae subspecies equisimilis (SDSE) causes disease and may provide important insights to aid in vaccine development.

17 Jun 2026

Sidewalk yeast species could lead to eco-friendly mosquito traps

An orange-colored yeast species isolated from a Baltimore sidewalk several years ago could be the basis of eco-friendly mosquito traps that reduce malaria transmission, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.

17 Jun 2026

Wastewater analysis offers novel approach to track HIV burden

Human immunodeficiency virus 1 (HIV-1) detection in wastewater offers a novel approach to monitor the virus in communities.

15 Jun 2026

Just ten viral particles can infect cows with bird flu

Just 10 viral particles of the H5N1 bird flu that caused hundreds of influenza outbreaks in U.S. dairy cattle can cause infection in cows, a new study shows.

15 Jun 2026

New mRNA flu vaccine offers broader protection against influenza strains

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today's standard flu shot, offering stronger and potentially longer-lasting protection.

15 Jun 2026

Global analysis exposes wide regional disparities in insecticide-treated net performance

A major analysis of 25 studies across Africa and Asia finds that insecticide-treated nets cut malaria cases by up to 68% - but highlights challenges that threaten to undermine their long-term impact.

15 Jun 2026

Progress and gaps shape India's tuberculosis control strategy

Announcing a new article publication for Zoonoses journal. Tuberculosis (TB) is among the main infectious diseases responsible for global mortality worldwide. Cases in India, markedly contribute to the global TB burden.

12 Jun 2026

Study links migrant status to slower NHS career progression

Ethnic minority healthcare workers who are also born overseas face a double disadvantage due to the combined effects of ethnicity and migrant status, according to new research published in JRSM Open.

12 Jun 2026

Metformin reduces long COVID risk according to ACTIV-6 clinical trial

New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.

11 Jun 2026

Key proteins enable louse-borne relapsing fever pathogen to evade immunity

Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice).

10 Jun 2026

Study identifies an important driver of inflammatory bowel disease

Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).

10 Jun 2026

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

Traveling for cosmetic surgery may carry hidden infection risks

A CDC review highlights serious infection risks linked to cosmetic surgery tourism, emphasizing the need for improved safety and infection control measures.

9 Jun 2026

$3.8 million grant funds study on early lung immune responses to tuberculosis

A University of Minnesota Medical School research team was awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to study early immune responses in the lung and how they influence tuberculosis infection outcomes.

8 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

8 Jun 2026

New open-access COVID-19 dataset supports reproducible clinical research

The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several Catalan healthcare and research institutions, has published the DIVINE study database in Scientific Data, a Nature Portfolio journal.

5 Jun 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026